医学
宫颈上皮内瘤变
高强度聚焦超声
前瞻性队列研究
组织病理学
治愈率
外科
超声波
泌尿科
妇科
内科学
宫颈癌
放射科
癌症
病理
作者
Yujuan Liu,Wenping Wang,Miao Zhang,Dacheng Qu,Chengchao Du,Yan Chen,Jiaojiao Reng,Liming Chen,Shengfeng Liu,Yamei Yang,Honggui Zhou
标识
DOI:10.1016/j.ultrasmedbio.2022.09.020
摘要
The aim of this study was to ascertain the safety of high-intensity focused ultrasound (HIFU) for high-grade cervical intraepithelial neoplasia grade 2/3 (CIN 2/3) in patients with fertility requirements. This was a prospective one-arm study. Consecutive CIN 2/3 patients diagnosed with histopathology were screened, enrolled and treated from September 2019 to September 2020 in the Affiliated Hospital of North Sichuan Medical College. All patients were treated with a combination of HIFU and antiviral treatment with REBACIN. The scheduled follow-up visits were 1 week, 1 mo, 3 mo, 6 mo and 12 mo after surgery. The primary outcomes included cure and human papillomavirus clearance rates. We screened 287 consecutive CIN 2/3 patients in our hospital, 29 of whom were enrolled and treated in this study. The cure rate reached 82.8% at 7 mo after treatment and 96.6% within 1 y. The HPV-negative rate reached 72.4% (21/29) around 6 mo after treatment, with mild side effects during and after the procedure. Our study suggests that in CIN 2/3 study participants with fertility requirements, HIFU + REBACIN therapy is a safe and effective therapeutic option with a high cure rate, HPV clearance and few side effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI